- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03008902
A Study of Effects of Age and Hyperkyphosis on Spine Motion and Loading
A Cross-sectional Study Using Motion Analysis to Determine Whether Age and Hyperkyphosis Are Associated With Thoracic Spine Motion and Loading
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to obtain unique measures of thoracic spinal motion in young, older, and hyperkyphotic older adults. We will then develop unique subject-specific musculoskeletal models of these individuals to estimate loads applied to the vertebrae in vivo, and examine how spinal motion and loading vary with age and increased kyphosis.
Vertebral fractures (VFs) are the most common type of fracture in older adults, occurring in 20-35% of women and 15-25% of men over the age of 50, and are associated with significant morbidity, increased mortality, and annual costs exceeding $1 billion in the United States. However, limited understanding of the mechanisms (beyond low vertebral bone mineral density and strength) that lead to VFs hinders our ability to predict and prevent these injuries.
Similarly, hyperkyphosis, defined as excess forward curvature of the thoracic spine, is suffered by 20-40% of older adults, but its causes are poorly understood and it has no standard clinical treatment. Hyperkyphosis and VFs are inter-related, as individuals with VFs often have worse kyphosis, while hyperkyphosis is an independent risk factor for future VFs. Hyperkyphosis may increase VF risk through increased vertebral loading, but better understanding is needed of the biomechanics of this common spine condition.
VFs occur more often at mid-thoracic (T7-T8) and thoraco-lumbar (T12-L1) vertebrae than elsewhere in the spine, and it has been suggested that biomechanical factors predispose these areas to fracture by increasing vertebral loading. In the first phase of this project, a novel musculoskeletal model was developed that uniquely predicts peaks in vertebral loading around the T12-L1 region of the spine, but this was not observed in the mid-thoracic region. Our preliminary data suggested that increased thoracic stiffness causes greater vertebral loading at mid-thoracic levels (T7-T9), while increased thoracic kyphosis increases vertebral loading, particularly in the thoraco-lumbar (T12-L1) region.
Further advances in musculoskeletal modeling will are needed to fully evaluate these possibilities, but a particular knowledge gap remains regarding the in vivo kinematics of the thoracic spine and ribcage in both healthy and hyperkyphotic individuals. This project aims to fill that gap by producing novel in vivo measurements of thoracic spine motion in young, older, and hyperkyphotic older adults.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Non-patients
Non-patients, who have not have not been seen at BIDMC for vertebral fractures or hyperkyphosis, will be recruited from the local community. The non-patient group will consist of 16 healthy adults ages 18-40.
Patients
Patients, who have been seen at BIDMC for vertebral fractures or hyperkyphosis, will be identified by review of medical records. The patient group will consist of 32 adults ages 75 and older who have previously been diagnosed with a thoracic vertebral fracture at BIDMC.
Description
No exclusion criteria shall be based on race, ethnicity, or sex.
Inclusion Criteria (Non-patient group):
- Males and females, ages 18 - 40 years
- Able to perform activities such as walking, standing, sitting, bending or lifting without assistance
- Willing to sign informed consent form
Exclusion Criteria (Non-patient group):
• Conditions that might alter thoracic biomechanics: Examples of these include scoliosis, a history of traumatic thoracic injury or spinal surgery, neuromuscular conditions such as Parkinson's disease or muscular dystrophy.
- Body mass index > 30 kg/m2
- Pregnancy
- Latex allergies
- Currently taking muscle relaxers, steroids, or narcotics
- Participation in another research study with radiation exposure
- Previous exposure to radiation as part of a medical procedure in the past six months
- Musculoskeletal injury or condition that is currently affecting normal activity or movement. Examples of this could include sprains, strains, dislocations or fractures that prevent one from walking, standing, sitting, bending or lifting in a normal manner.
Inclusion Criteria (Patient group):
- Males and females, ages 75 years and older.
- Patients who received a lateral thoracic spine x-ray and had a diagnosis of a vertebral fracture (ICD9 - 805.2) in the year 2011 or later.
- At least 6 months since diagnosis of vertebral fracture.
- Measurable T4-T12 Cobb angle in lateral thoracic spine x-ray.
- Currently living in the Boston area.
- Able to perform activities such as walking, standing, sitting, bending or lifting without assistance
- Willing to sign informed consent form
Exclusion Criteria (Patient group):
• Conditions (unrelated to vertebral fracture and hyperkyphosis) that might alter thoracic biomechanics: Examples of these include scoliosis, a history of traumatic thoracic injury or spinal surgery, neuromuscular conditions such as Parkinson's disease or muscular dystrophy.
- Body mass index > 30 kg/m2
- Latex allergies
- Currently taking muscle relaxers, steroids, or narcotics
- Musculoskeletal injury or condition that is currently affecting normal activity or movement. Examples of this could include sprains, strains, dislocations or fractures that prevent one from walking, standing, sitting, bending or lifting in a normal manner.
- A score ≥10 on the Short Blessed Test, suggesting possible impaired cognitive function or dementia.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Non-patients
Non-patients, who have not had vertebral fractures or hyperkyphosis, and have not been seen at BIDMC, will be recruited from the community as described in section B3C and B6 below.
The non-patient group will consist of 16 healthy adults ages 18-40.
|
Full body movement will be recorded during movements using near infrared passive motion capture.
This procedure is non-invasive and standard practice in biomechanics labs.
Movement will be recorded using an eight-camera system.
Retroreflective markers are placed at strategic joint locations to characterize limb movement.
Accuracies of the marker positions are sub-millimeter, and allow accurate characterization of limb rotation and translation during movements.
Passive reflective marker clusters (3 markers each) will be attached to subjects at 8 locations along the spine.
Additional markers will be applied to the manubrium of the sternum, head, pelvis, and extremities.
Eight EMG surface electrode pairs will be used to record activation from the left and right erector spinae, latissimus dorsi, trapezius and rectus abdominis muscles during all motions.
|
Patients
Patients, who have been seen at BIDMC for vertebral fractures or hyperkyphosis, will be identified by review of medical records as described in B3C and B6 below.
The patient group will consist of 32 adults ages 75 and older who have previously been diagnosed with a thoracic vertebral fracture at BIDMC.
|
Full body movement will be recorded during movements using near infrared passive motion capture.
This procedure is non-invasive and standard practice in biomechanics labs.
Movement will be recorded using an eight-camera system.
Retroreflective markers are placed at strategic joint locations to characterize limb movement.
Accuracies of the marker positions are sub-millimeter, and allow accurate characterization of limb rotation and translation during movements.
Passive reflective marker clusters (3 markers each) will be attached to subjects at 8 locations along the spine.
Additional markers will be applied to the manubrium of the sternum, head, pelvis, and extremities.
Eight EMG surface electrode pairs will be used to record activation from the left and right erector spinae, latissimus dorsi, trapezius and rectus abdominis muscles during all motions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thoracic spine range of motion, in degrees.
Time Frame: Day 1
|
Full body movement will be recorded during subject movements using near infrared passive motion capture.
This procedure is non-invasive and standard practice in biomechanics labs.
Passive reflective marker clusters will be attached to subjects along the spine at T1, T4, T5, T8, T9, T12, L1, and additional markers will be applied to the manubrium of the sternum, head, pelvis, and extremities.
Marker positions during subject movements will be recorded with sub-millimeter accuracy using an eight-camera system from Vicon Motion Systems (Centennial, CO).
Recorded marker positions will be applied to a musculoskeletal model of the subject through an inverse kinematics algorithm in order to provide estimates of thoracic spine angular range of motion in flexion-extension, lateral bending, and axial rotation during each subject movement.
|
Day 1
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Dennis Anderson, Ph.D., Beth Israel Deaconess Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015P000394
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vertebral Fracture
-
AgNovos Healthcare, LLCRecruitingVertebral Fracture | Vertebral Compression Fracture | Vertebral CompressionGermany, Spain
-
AgNovos Healthcare, LLCRecruitingVertebral Compression Fracture | Vertebral Compression | Compression FractureUnited States
-
University of Texas Southwestern Medical CenterMedtronicCompletedLumbar Vertebral FractureUnited States
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
University Hospital, Clermont-FerrandCompletedVertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures (VOLCANO)Vertebral Compression Fracture | Spinal TraumaFrance
-
Icahn School of Medicine at Mount SinaiRecruitingVertebral Compression Fractures | Osteoporotic Vertebral Compression FracturesUnited States
-
Jaseng Medical FoundationRecruitingVertebral Compression Fracture | Vertebral Compression | Korean Traditional Medicine | Integrative Korean MedicineKorea, Republic of
-
Hospital for Special Surgery, New YorkCompletedVertebral Compression FractureUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingPrediction Model | Osteoporotic Vertebral FractureChina
-
Northwell HealthCompletedVertebral Fracture | Vertebral Compression | Vertebra Compression FractureUnited States
Clinical Trials on Near-infrared passive motion capture recording
-
Swiss Federal Institute of TechnologyUniversity of Zurich; cereneo center for Neurology and RehabilitationRecruitingParkinson Disease | Gait Disorders, NeurologicSwitzerland
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIM Inria Université Paris-Saclay; Laboratoire...RecruitingGeneral AnesthesiaFrance
-
University Hospital, ToulouseRecruiting
-
University Hospital Inselspital, BerneEdwards LifesciencesCompletedVasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, HighSwitzerland